| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Schoenberg Mark is a Chief Medical Officer at UroGen Pharma Ltd.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $5.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 243 | $15.64 | $3,800.52 | -1.1% | +8.9% | -51.9% | |
| Jul 26, 2021 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 103 | $15.30 | $1,575.90 | -0.5% | +7.8% | -47.4% | |
| Apr 30, 2021 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 243 | $20.00 | $4,860.00 | -1.1% | -20.4% | -63.7% | |
| Apr 26, 2021 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 89 | $19.63 | $1,747.07 | -0.4% | -26.5% | -65.1% | |
| Jan 31, 2021 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 1,076 | $22.07 | $23,747.32 | -4.9% | - | - | |
| Jan 26, 2021 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 100 | $22.12 | $2,212.00 | -0.5% | - | - | |
| Dec 4, 2020 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 662 | $19.85 | $13,140.70 | -3.2% | - | - | |
| Oct 26, 2020 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 101 | $20.95 | $2,115.56 | -0.5% | - | - | |
| Sep 4, 2020 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 348 | $20.20 | $7,029.60 | -1.8% | - | - | |
| Jul 27, 2020 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 70 | $23.51 | $1,645.70 | -0.4% | - | - |